High Risk: The Debate Over the Price of Specialty Drugs and Zika Virus
In an interview with CFIF, Dr. Scott Gottlieb, Resident Fellow at the American Enterprise Institute, discusses the history and regulations surrounding drug prices, who should finance important medical advancements, and the continuing Zika threat.
"The first Clinton-Trump debate was roughly a draw -- which is bad news for her, because she needs to turn this race around, and she failed. ...Donald Trump remains the candidate of change; Hillary Clinton, the tribune of the status quo."…[more]